Valacyclovir (Valtrex) for Oral Herpes
Valacyclovir (Valtrex - GlaxoSmithKline) was recently approved by the FDA for one-day oral treatment of patients at least 12 years old with orolabial herpes simplex infections. The drug was previously approved for treatment and suppression of genital herpes and for treatment of herpes zoster (shingles)....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Valacyclovir (Valtrex) for Oral Herpes
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1143
Article Code: 1143a
Date: November 11, 2002
Volume: 44
Pages: 95-96
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1143
Article Code: 1143a
Date: November 11, 2002
Volume: 44
Pages: 95-96
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)